Follow us
Product Innovations
Pulmonary Delivery of Orally Inhaled Therapeutics
New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...
In Vivo Evaluation of a Gastro-Resistant HPMC-Based “Next Generation Enteric” Capsule
Invivo: Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach....
ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization
Assessing key parameters of the upstream process to achieve high titer while maintaining desired integrity
Customizing the downstream process to...